Archer Materials Limited (AU:AXE) has released an update.
Archer Materials Limited has started experiments with its Biochip gFET sensors for the detection of potassium levels, an essential indicator in chronic kidney disease. The company has improved the stability and performance of these sensors by directly growing graphene surfaces, which do not degrade in air over time. This advancement is a critical step towards developing home-based diagnostic devices for monitoring renal health, marking a leap in accessible healthcare technology.
For further insights into AU:AXE stock, check out TipRanks’ Stock Analysis page.
